The importance of LILRB2 in human atherosclerosis is increasingly evident with reports linking the LILRB2 ligand ANGPTL2 to cardiovascular disease (Gellen et al., 2016; Tian et al., 2016; Tian et al., 2018). Here, ANGPTL2 is linked to atherosclerosis.